Methods for constructing and evaluating antitumor DNA vaccines

Methods in Molecular Biology

Volumn 542, Issue , 2009, Pages 211-243

  Olson, Brian M ^a   McNeel, Douglas G ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

DNA vaccine; immunization; immunotherapy; plasmid purification; tumor antigen

Indexed keywords

BACTERIA (MICROORGANISMS); EUKARYOTA;

CANCER VACCINE; DNA VACCINE; TUMOR ANTIGEN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHO CELL; CRICETULUS; HAMSTER; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY; MOUSE; RAT; REPRODUCIBILITY;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CHO CELLS; CRICETINAE; CRICETULUS; MICE; MOLECULAR BIOLOGY; RATS; REPRODUCIBILITY OF RESULTS; VACCINES, DNA;

EID: 67650306160     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_12     Document Type: Review

References (36)

1. Liu , M. A.2003) DNA vaccines: a review J Intern Med 253 , 402-10
2. Van der Bruggen , P. and Van den Eynde , B. J.2006) Curr Opin Immunol 18 , 98-104
3. Ciernik , I. F. , Berzofsky , J. A. , and Carbone , D. P.1996) Processing and presentation of tumor antigens and vaccination strategies J Immunol 156 , 2369-75
4. Pilon , S. A. , Piechocki , M. P. , and Wei , W. Z.2001) Vaccination with cytoplasmic ErbB-2 DNA protects mice from mammary tumor growth without anti-ErbB-2 antibody J Immunol 167 , 3201-6
5. Roos , A. K. , Pavlenko , M. , Charo , J. , Egevad , L. , and Pisa , P.2005) Induction of PSAspecific CTLs and anti-tumor immunity by genetic prostate cancer vaccine Prostate 62 217-23
6. Cassaday , R. D. , Sondel , P. M. , King , D. M. , Macklin , M. D. , Gan , J. , Warner , T. F. , Zuleger , C. L. , Bridges , A. J. , Schalch , H. G. , Kim , K. M. , Hank , J. A. , Mahvi , D. M. , and Albertini , M. R.2007) A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients Clin Cancer Res 13 , 540-9
7. Liu , M. A. and Ulmer , J. B.2005) Human clinical trials of plasmid DNA vaccines Adv Genet 55 , 25-40
8. Pavlenko , M. , Roos , A. K. , Lundqvist , A. , Palmborg , A. , Miller , A. M. , Ozenci , V. , Bergman , B. , Egevad , L. , Hellstrom , M. , Kiessling , R. , Masucci , G. , Wersall , P. , Nilsson , S. , and Pisa , P.2004) A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer Br J Cancer 91 , 688-94
9. Triozzi , P. L. , Aldrich , W. , Allen , K. O. , Carlisle , R. R. , LoBuglio , A. F. , and Conry , R. M.2005) Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse J Immunother (1997) 28 , 382-8
10. Zlotocha , S. , Staab , M. J. , Horvath , D. , Straus , J. , Dobratz , J. , Oliver , K. , Wasielewski , S. , Alberti , D. , Liu , G. , Wilding , G. , Eickhoff , J. , and McNeel , D. G.2005) Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse Clin Genitourin Cancer 4 , 215-8
11. Nichols , W. W. , Ledwith , B. J. , Manam , S. V. , and Troilo , P. J.1995) Potential DNA vaccine integration into host cell genome Ann N Y Acad Sci 772 , 30-9
12. Wolff , J. A. , Malone , R. W. , Williams , P. , Chong , W. , Acsadi , G. , Jani , A. , and Felgner , P. L.1990) Direct gene transfer into mouse muscle in vivo Science 247 , 1465-8
13. Disis , M. L. , Shiota , F. M. , McNeel , D. G. , and Knutson , K. L.2003) Direct gene transfer into mouse muscle in vivo Immunobiology 207 , 179-86
14. McNeel , D. G. , Schiffman , K. , and Disis , M. L.1999) Immunization with recombinant human granulocyte-macrophage colonystimulating factor as a vaccine adjuVant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor Blood 93 , 2653-9
15. Hemmi , H. , Takeuchi , O. , Kawai , T. , Kaisho , T. , Sato , S. , Sanjo , H. , Matsumoto , M. , Hoshino , K. , Wagner , H. , Takeda , K. , and Akira , S.2000) A Toll-like receptor recognizes bacterial DNA Nature 408 , 740-5
16. Klinman , D. M. , Yamshchikov , G. , and Ishigatsubo , Y.1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines J Immunol 158 , 3635-9
17. Krieg , A. M. , Yi , A. K. , Schorr , J. , and Davis , H. L.1998) The role of CpG dinucleotides in DNA vaccines Trends Microbiol 6 , 23-7
18. Garmory , H. S. , Brown , K. A. , and Titball , R. W.2003) DNA vaccines: improving expression of antigens Genet Vaccines Ther 1 , 2
19. Weeratna , R. D. , Wu , T. , Efler , S. M. , Zhang , L. , and Davis , H. L.2001) Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters Gene Ther 8 , 1872 - 8
20. Hornung , V. , Rothenfusser , S. , Britsch , S. , Krug , A. , Jahrsdorfer , B. , Giese , T. , Endres , S. , and Hartmann , G.2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides J Immunol 168 , 4531-7
21. Liu , M. A. , Wahren , B. , and Karlsson Hedestam , G. B.2006) DNA vaccines: recent developments and future possibilities Hum Gene Ther 17 , 1051-61
22. Hengge , U. R. , Walker , P. S. , and Vogel , J. C.1996) Expression of naked DNA in human, pig, and mouse skin J Clin Invest 97 , 2911-6
23. Raz , E. , Carson , D. A. , Parker , S. E. , Parr , T. B. , Abai , A. M. , Aichinger , G. , Gromkowski , S. H. , Singh , M. , Lew , D. , Yankauckas , M. A. , and et al.1994) Expression of naked DNA in human, pig, and mouse skin Proc Natl Acad Sci USA 91 , 9519-23
24. Fynan , E. F. , Webster , R. G. , Fuller , D. H. , Haynes , J. R. , Santoro , J. C. , and Robinson , H. L.1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations Proc Natl Acad Sci USA 90 , 11478-82
25. Pertmer , T. M. , Eisenbraun , M. D. , McCabe , D. , Prayaga , S. K. , Fuller , D. H. , and Haynes , J. R.1995) Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA Vaccine 13 , 1427-30
26. Lyerly , H. K.2003) Quantitating cellular immune responses to cancer vaccines Semin Oncol 30 , 9-16
27. Whiteside , T. L.2004) Methods to monitor immune response and quality control Dev Biol (Basel) 116 , 219 - 28 ; discussion 29-36.
28. Mosca , P. , Clay , T. , Morse , M. , and Lyerly , H. K.2005) Tumor immunology and cancer vaccines: immune monitoring Cancer Treat Res 123 , 369-88
29. Clay , T. M. , Hobeika , A. C. , Mosca , P. J. , Lyerly , H. K. , and Morse , M. A.2001) Assays for monitoring cellular immune responses to active immunotherapy of cancer Clin Cancer Res 7 , 1127-35
30. Hernandez-Fuentes , M. P. , Warrens , A. N. , and Lechler , R. I.2003) Immunologic monitoring Immunol Rev 196 , 247-64
31. Nestle , F. O. , Tonel , G. , and Farkas , A.2005) Cancer vaccines: the next generation of tools to monitor the anticancer immune response PLoS Med 2 , e339
32. Manthorpe , M. , Cornefert-Jensen , F. , Hartikka , J. , Felgner , J. , Rundell , A. , Margalith , M. , and Dwarki , V.1993) Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice Hum Gene Ther 4 , 419-31
33. Wolff , J. A. , Williams , P. , Acsadi , G. , Jiao , S. , Jani , A. , and Chong , W.1991) Conditions affecting direct gene transfer into rodent muscle in vivo Biotechniques 11 , 474-85
34. Chang , D. Z. , Lomazow , W. , Joy Somberg , C. , Stan , R. , and Perales , M. A.2004) Granulocyte-macrophage colony stimulating factor: an adjuVant for cancer vaccines Hematology 9 , 207-15
35. Pan , C. H. , Chen , H. W. , and Tao , M. H.1999) Modulation of immune responses to DNA vaccines by codelivery of cytokine genes J Formos Med Assoc 98 , 722-9
36. Mattner , F. , Fleitmann , J. K. , Lingnau , K. , Schmidt , W. , Egyed , A. , Fritz , J. , Zauner , W. , Wittmann , B. , Gorny , I. , Berger , M. , Kirlappos , H. , Otava , A. , Birnstiel , M. L. , and Buschle , M.2002) Vaccination with poly- L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens Cancer Res 62 , 1477-80